Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomically-Guided Treatment Trial in Brain Metastases

NCT03994796 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT03994796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03994796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomically-Guided Treatment Trial in Brain Metastases
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 17, 2019
Completion date
June 30, 2028
Enrollment
50 (actual)
Sites
435

Conditions

As the registry lists them; a condition with its own page is linked.

cdk gene mutation, kras g12c mutation, metastatic malignant neoplasm in the brain, metastatic malignant solid neoplasm, ntrk family gene mutation, pi3k gene mutation, ros1 gene mutation